1. Home
  2. FOXA vs BIIB Comparison

FOXA vs BIIB Comparison

Compare FOXA & BIIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fox Corporation

FOXA

Fox Corporation

HOLD

Current Price

$73.91

Market Cap

26.5B

Sector

Industrials

ML Signal

HOLD

Logo Biogen Inc.

BIIB

Biogen Inc.

HOLD

Current Price

$176.33

Market Cap

24.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOXA
BIIB
Founded
2018
1978
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.5B
24.2B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
FOXA
BIIB
Price
$73.91
$176.33
Analyst Decision
Buy
Buy
Analyst Count
14
22
Target Price
$71.15
$177.40
AVG Volume (30 Days)
3.6M
2.4M
Earning Date
02-03-2026
02-11-2026
Dividend Yield
0.76%
N/A
EPS Growth
9.15
N/A
EPS
4.44
10.97
Revenue
$16,474,000,000.00
$10,065,900,000.00
Revenue This Year
$0.74
$3.58
Revenue Next Year
$4.24
N/A
P/E Ratio
$16.64
$16.07
Revenue Growth
14.90
4.77
52 Week Low
$46.42
$110.04
52 Week High
$74.63
$185.17

Technical Indicators

Market Signals
Indicator
FOXA
BIIB
Relative Strength Index (RSI) 77.78 57.23
Support Level $70.09 $168.56
Resistance Level $74.63 $177.29
Average True Range (ATR) 1.45 4.81
MACD 0.22 -1.03
Stochastic Oscillator 89.50 53.27

Price Performance

Historical Comparison
FOXA
BIIB

About FOXA Fox Corporation

Fox operates in two segments: cable networks and television. Cable networks primarily includes Fox News, Fox Business, and several pay TV sports stations. Television primarily includes the Fox broadcast network, 29 owned and operated local television stations, of which 18 are affiliated with the Fox network, and streaming platform Tubi, which is not subscription-based and is completely ad-supported. Fox effectively sold most of its entertainment assets to Disney in 2019, so it no longer creates entertainment content and relies heavily on live news and sports, with nearly all tied to the pay TV bundle. The Murdoch family controls Fox.

About BIIB Biogen Inc.

Biogen is an established biopharmaceutical company focused on treatments for neurological diseases and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 45% of total revenue in 2024. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (18% of total in 2024), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).

Share on Social Networks: